SPRB — SPRUCE BIOSCIENCES, INC.
Price · 2024-08-26 → 2026-08-21
499 daily closes shownAnonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2020-10-09.
Performance
Technicals
Others in Healthcare
Measured signals that fired on SPRB
| date | signal | measured base rate |
|---|---|---|
| 2026-07-23 | Equal lows taken out structure | -0.64% over 21 days · t = -4.75 · n = 55,661 statistically distinguishable from its control group |
| 2026-05-28 | Equal lows taken out structure | -0.64% over 21 days · t = -4.75 · n = 55,661 statistically distinguishable from its control group |
Excess return against a matched control group, on a point-in-time universe that includes delisted companies. Most families do not survive that. How the measurement works →
Insider transactions (Form 4)
| date | insider | what | shares | price | value |
|---|---|---|---|---|---|
| 2026-06-30 | Szwarcberg Javier B. CHIEF EXECUTIVE OFFICER | Grant or award | 266 | 4.53 | 1.2K |
| 2025-12-31 | Szwarcberg Javier B. CHIEF EXECUTIVE OFFICER | Grant or award | 4.7K | 4.53 | 21.2K |
| 2025-12-15 | Szwarcberg Javier B. CHIEF EXECUTIVE OFFICER | Shares withheld for tax | 752 | 80.67 | 60.7K |
| 2025-12-15 | Szwarcberg Javier B. CHIEF EXECUTIVE OFFICER | Shares withheld for tax | 608 | 80.67 | 49.0K |
| 2025-12-15 | Gharib Samir M. PRESIDENT AND CFO | Shares withheld for tax | 184 | 80.67 | 14.8K |
| 2025-12-15 | Gharib Samir M. PRESIDENT AND CFO | Shares withheld for tax | 178 | 80.67 | 14.4K |
| 2025-12-15 | Gharib Samir M. PRESIDENT AND CFO | Option exercise | 513 | 0.00 | 0 |
| 2025-12-15 | Szwarcberg Javier B. CHIEF EXECUTIVE OFFICER | Option exercise | 1.5K | 0.00 | 0 |
| 2025-12-15 | Gharib Samir M. PRESIDENT AND CFO | Option exercise | 496 | 0.00 | 0 |
| 2025-12-15 | Szwarcberg Javier B. CHIEF EXECUTIVE OFFICER | Option exercise | 1.2K | 0.00 | 0 |
Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →
Largest institutional holders
| manager | value | shares |
|---|---|---|
| Ikarian Capital, LLC | 7.9M | 121.4K |
| MILLENNIUM MANAGEMENT LLC | 7.3M | 111.9K |
| CITADEL ADVISORS LLC | 4.6M | 70.0K |
| ADAR1 Capital Management, LLC | 3.8M | 58.6K |
| Alyeska Investment Group, L.P. | 3.4M | 51.7K |
| WELLINGTON MANAGEMENT GROUP LLP | 3.2M | 48.8K |
| BOOTHBAY FUND MANAGEMENT, LLC | 2.7M | 42.1K |
| Balyasny Asset Management L.P. | 2.6M | 40.0K |
| Carlyle Group Inc. | 2.5M | 38.6K |
| Quinn Opportunity Partners LLC | 1.8M | 26.8K |
13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →
Short selling
This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →
Recent headlines
- Spruce Biosciences Q2 Loss Widens; Names Adrian Quarterl CMO, Jessica Cohen VP - Clinical · 2026-08-12
- Spruce Biosciences GAAP EPS of -$6.68 · 2026-08-12
- Spruce Biosciences, Inc. (SPRB) filed form 8-K · 2026-08-12 · SEC EDGAR
Ask the AI about SPRB
The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.
Everything on this page is live in the terminal.
Charts, filings, insider flow and the AI — open without an account.
Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →